II
iQSTEL Inc (IQST)·Q2 2025 Earnings Summary
Executive Summary
- Q2 2025 consolidated revenue was $72.18M, up 25.3% sequentially vs Q1 2025 ($57.63M), but down 8.2% year-over-year vs Q2 2024 ($78.64M). Gross profit was $1.87M with a 2.59% gross margin, and EBITDA was -$0.48M [GetFinancials, Q2’25: Revenues, Gross Profit, Gross Margin, EBITDA; Q1’25: Revenues; Q2’24: Revenues, Gross Profit, Gross Margin]*.
- The company highlighted balance sheet strength: stockholders’ equity rose to $14.29M and assets were $51.4M ($17.41 per share), with telecom division net income of $321,321 in Q2 and H1 telecom EBITDA of $1.106M .
- Against S&P Global consensus, IQST modestly beat revenue ($72.18M vs $70.34M) and beat EPS (-$0.44 vs -$0.50), while EBITDA missed (-$0.48M vs -$0.25M) [GetEstimates for Q2 2025, S&P Global]*.
- Management reaffirmed FY-2025 revenue guidance at $340M and accelerated the $400M annualized run-rate to Q3 (prior target year-end), citing the consolidation of Globetopper and July revenue of ~$35M as catalysts .
What Went Well and What Went Wrong
What Went Well
- Balance sheet and per-share value improved: net stockholders’ equity increased to $14.29M and equity per share to $4.84; assets per share reached $17.41 .
- Telecom profitability strengthened: telecom division net income rose 29.94% QoQ to $321,321, and H1 telecom EBITDA reached $1.106M .
- Run-rate pulled forward: preliminary H1 revenue was $128.8M and July revenue was ~$35M, supporting a $400M annualized run-rate in Q3, ahead of plan .
- Quote: “With accelerating adjusted EBITDA and the positive impact of our debt reduction coming in Q3, we are well-positioned for a strong second half of 2025.” — CEO Leandro Iglesias .
What Went Wrong
- EBITDA and net income remained negative at the consolidated level: Q2 EBITDA -$0.48M and net income -$2.41M [GetFinancials, Q2’25: EBITDA, Net Income]*.
- YoY revenue decline: Q2 2025 revenue of $72.18M was below Q2 2024 revenue of $78.64M, despite management emphasizing organic growth and intercompany routing efficiencies [GetFinancials, Q2’25/Q2’24 Revenues]* .
- Margin volatility: gross margin in Q2 2025 was 2.59%, lower than Q1 2025 (3.36%), with management citing synergies and intercompany transactions that optimize costs over time; the release noted margin improvements on an H1 basis (+7.45%/+7.65% vs prior year), suggesting mixed quarter-to-quarter dynamics [GetFinancials, Q2’25/Q1’25 Gross Margin]* .
Financial Results
Consolidated Performance vs Prior Periods
Note: Values marked with * are retrieved from S&P Global.
Results vs S&P Global Consensus (Q2 2025)
All estimate values are retrieved from S&P Global.
Segment/Mix and KPIs
Guidance Changes
Earnings Call Themes & Trends
No Q2 2025 earnings call transcript was available in our document corpus through Sept 30, 2025; analysis is based on 8-Ks and press releases [ListDocuments: earnings-call-transcript=none].
Management Commentary
- “Our Q2 results confirm the strength of our balance sheet, the profitability of our core business, and the scalability of our operations… we are well-positioned for a strong second half of 2025.” — Leandro Jose Iglesias, CEO .
- “We are on track to achieve $210 million revenue in the second half of 2025… setting the stage for a $400 million revenue run rate.” .
- “We think long-term… to ensure IQSTEL is ready to lead our industry into the next decade.” .
Q&A Highlights
Not applicable — no Q2 2025 earnings call transcript was available in the document corpus; therefore Q&A highlights and clarifications could not be assessed [ListDocuments: earnings-call-transcript=none].
Estimates Context
- Revenue beat: Actual $72.18M vs consensus $70.34M; EPS beat: Actual -$0.4441 vs consensus -$0.50; EBITDA miss: Actual -$0.48M vs consensus -$0.25M. With only one estimate for EPS and revenue, dispersion is limited; the modest top-line beat coupled with EBITDA below expectations suggests mix and cost dynamics remained a headwind in Q2 [GetEstimates, S&P Global]*.
- The acceleration of the annualized run-rate to Q3 and consolidation of Globetopper may lead to upward revisions to revenue forecasts, while EBITDA trajectories will depend on margin capture and operational streamlining highlighted by management .
All estimate values are retrieved from S&P Global.
Key Takeaways for Investors
- Revenue is scaling with sequential growth and an accelerated run-rate, supported by July’s ~$35M and Globetopper consolidation; near-term upside skew comes from sustained monthly volumes and execution on AI-driven offerings .
- Despite revenue beats, EBITDA and net income at the consolidated level remain negative; monitoring margin capture from intercompany synergies and tech mix will be critical to bridge toward the $15M EBITDA run-rate goal [GetFinancials, Q2’25 EBITDA/Net Income]* .
- Balance sheet strengthening (equity up to $14.29M; $3.5M debt reduction in Q3) underpins per-share value and capacity for disciplined M&A, an explicit lever for EBITDA scaling .
- Institutional participation is rising post-uplisting; paired with external research support (Buy, $18–$22 target), potential valuation recalibration hinges on delivering EBITDA growth in H2 and 2026 .
- Guidance is stable at $340M FY revenue with timelines pulled forward for the $400M run-rate; execution risk centers on monthly run-rate durability and margin improvement trajectory .
- Actionable: near-term trading catalysts include monthly revenue updates and Q3 disclosures reflecting debt reduction and Globetopper impact; medium-term thesis anchors on AI/tech mix expansion and M&A-driven EBITDA scaling .
Notes:
- Values marked with * in tables are retrieved from S&P Global.